semaglutide asa guidelines anesthesia for glp 1 glp-1 2025 Not all trends are risk-free—especially before surgery. If you' Advises No Longer Holding – ASA classification isn't just a

These medications are also known as GLP-1 analogs, incretin mimetics, and GLP-1 RAs

Co-occurring Anti-diabetic Medications Overall, oral semaglutide users commonly received one (23.9%), two (36.6%), or three (29.1%) co-occurring anti-diabetic medications, these mainly consisting of biguanides (79.5%) and SGLT-2i (42.3%)

This is because the vasodilatory effects of GLP-1 receptor activation and the blood volume reduction from weight loss more than compensate for the increased cardiac output

GLP-1 use is safe and effective with many pre-existing conditions with the exception of the following: Currently pregnant Currently breastfeeding Currently being treated for cancer Active eating disorder Active gallbladder disease Active substance abuse or dependency Type 1 diabetes Bariatric surgery (within the past 18 months) Pancreatitis within the past 6 months, or a history of pancreatiitis caused by taking a GLP-1 Personal or family history of medullary thyroid cancer or MEN syndrome Personal history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)